|
|
|
| Discussion on the pathogenesis of pulmonary nodules “deficiency of lung qi and obstruction of lung collaterals by toxin” under the guidance of collateral disease theory |
| ZHOU Jie1* WANG Yuehui1* LI Zhiming1 YANG Lihui1 LI Quanwang2 |
1.Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Oncology, Oriental Hospital, Beijing University of Chinese Medicine, Beijing 100078, China |
|
|
|
Abstract With the development of examination technology, more and more pulmonary nodules are found in the earlier stage. In the process of long-term diagnosis and treatment, director Li Quanwang takes root in the classical collateral disease theory of traditional Chinese medicine, combined with the clinical characteristics of pulmonary nodules, and thinks that pulmonary nodules belong to pulmonary collateral disease. Based on the epidemiological data and treatment progress of pulmonary nodules, combined with the psychological and physical bias of patients, it is considered that traditional Chinese medicine should be applied to the early diagnostic treatment of pulmonary nodules. It is put forward that the pathogenesis of pulmonary nodules is “deficiency of lung qi and obstruction of lung collaterals by toxin”, and the treatment principle of “regulating qi and strengthening vital qi, detoxification and dredging collaterals”. In clinic, collateral disease, lung collaterals, traditional Chinese medicine lung and pulmonary nodules are organically combined to form a perfect “structure-function-disease” network, which broadens the train of thought and provides clinical basis for the treatment of pulmonary nodules with traditional Chinese medicine.
|
|
|
|
|
|
[1] Cao MM，Chen WQ. Epidemiology of lung cancer in China [J].Thorac Cancer，2019，10（1）：3-7.
[2] Hassan T，Piton N，Lachkar S，et al. A novel method for in vivo imaging of solitary lung nodules using navigational bronchoscopy and confocal laser microendoscopy [J]. Lung，2015，193（5）：773-778.
[3] 叶天士.临证指南医案[M].上海：上海科学技术出版社，1959.
[4] 张志聪.黄帝内经集注[M].杭州：浙江古籍出版社，2002.
[5] 吴以岭.络病病机探析[J].中医杂志，2005，46（4）：243-245.
[6] 中华医学会呼吸病学分会肺癌学组.中国肺癌防治联盟专家组.肺结节诊治中国专家共识（2018年版）[J].中华结核和呼吸杂志，2018，41（10）：763-771.
[7] Henschke CI，Yankelevitz DF，Mirtcheva R，et al. CT screening for lung cancer：frequency and significance of part-solid and nonsolid nodules [J]. AJR Am J Roentgenol，2002，178（5）：1053-1057.
[8] Baldwin DR，Callister ME. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules [J]. Thorax，2015，70（8）：794-798.
[9] 王小铭，郑钦允.低剂量多层螺旋CT对717例健康体检者的肺结节筛查分析[J].肿瘤学杂志，2018，23（11）：1-3.
[10] 李铭，高丰，郑向鹏，等.肺内亚厘米磨玻璃结节的CT诊断与鉴别[J].实用放射学杂志，2014，30（3）：416-420.
[11] MacMahon H，Naidich DP，Goo JM，et al. Guidelines for management of incidental pulmonary nodules detected on CT images：from the Fleischner Society 2017 [J]. Radiology，2017，284（1）：228-243.
[12] Detterbeck FC，Boffa DJ，Kim AW，et al. The eighth edition lung cancer stage classification [J]. Chest，2017，151（1）：193-203.
[13] Ettinger DS，Aisner DL，Wood DE，et al. NCCN guidelines insights：non-small cell lung cancer，version 5.2018 [J]. J Natl Compr Canc Netw，2018，16（7）：807-821.
[14] Gould MK，Fletcher J，Iannettoni MD，et al. Evaluation of patients with pulmonary nodules：when is it lung cancer？：ACCP evidence-based clinical practice guidelines [J]. Chest，2007，132（3）：108S-130S.
[15] Bai C，Choi CM，Chu CM，et al. Evaluation of pulmonary nodules：clinical practice consensus guidelines for Asia [J]. Chest，2016，150（4）：877-893.
[16] 周清华，范亚光，王颖，等.中国肺部结节分类、诊断与治疗指南[J].中国肺癌杂志，2016，19（12）：793-798.
[17] Chang B，Hwang JH，Choi YH，et al. Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT Scan [J]. Chest，2013，143（1）：172-178.
[18] 付金花，陈武飞，滑炎卿.倍增时间在磨玻璃结节随访中的应用价值[J].临床放射学杂志，2017，36（6）：886-888.
[19] Kakinuma R，Noguchi M，Ashizawa K，et al. Natural History of Pulmonary Subsolid Nodules：A Prospective Multicenter Study [J]. J Thorac Oncol，2016，7（11）：1012-1028.
[20] 陆王娟，周贤梅.中医体质在肺结节早期诊治中的应用探讨[J].陕西中医，2018，39（4）：518-520.
[21] 徐佳仪.肺部小结节患者中医体质分布规律探析[D].杭州：浙江中医药大学，2019.
[22] 许海柱，祝佳佳，张栩，等.381例肺小结节患者中医体质分布特点研究[J].时珍国医国药，2019，30（9）：2178-2180.
[23] 郭倩倩，赵帅，苏懿，等.中医体质分类与肺癌预后因素相关性分析[J].辽宁中医药大学学报，2012，14（3）：112-115.
[24] 朱进看.肺微小结节的病理分布及张纾难教授中药治疗规律初探[D].北京：北京中医药大学，2019.
[25] 于小林，张晓梅，顾潇枫，等.张晓梅从状态论治肺结节经验[J].中华中医药杂志，2018，33（11）：4984-4986.
[26] 魏华民，朱瑞丽，刘瑞，等.从痰瘀窠囊论治肺结节[J].世界中医药，2018，13（11）：2701-2705，2708.
[27] 刘敏，朱佳.朱佳教授治疗肺结节中医思路[J].辽宁中医药大学学报，2018，20（9）：89-91.
[28] 许海柱，潘永福.潘永福教授治疗孤立性肺小结节的用药规律探析[J].中医药学报，2018，46（5）：93-96.
[29] 朱丽娜，刘丽坤.中医治疗孤立性肺结节思路探讨[J].亚太传统医药，2019，15（2）：79-81.
[30] 侯秋月.理气解郁、化痰散结法治疗肺小结节的临床研究[D].南京：南京中医药大学，2019.
[31] 孙凯.周围型孤立性肺小结节的诊疗分析[D].济南：山东大学，2014.
[32] 丁元庆.从“久病入络”、“久痛入络”探讨络病的特点[J].疑难病杂志，2006，5（1）：31-33. |
|
|
|
